12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Company News  |  Deals

Apeiron Biologics, Evotec deal

The companies partnered to identify lead compounds against casitas B cell lymphoma-b (Cbl-b) to treat cancer. Both parties will retain rights to any compounds identified,...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >